In 2006, Krause et al. [49] demonstrated homing and engraftment of CML LSCs is characterized by dependence on the CD44 receptor and reduced reliance on CXCR4 and its ligand, CXCL12 (Fig. 4). This evidence concerns the gene CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive.